La cadena de opciones muestra datos clave de las opciones de acciones de Fangdd Network Group a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Fangdd Network Group..

Fangdd Network Group (NASDAQ:DUO) Bolsa, Cadena de Opciones

Fangdd Network Group

Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.

Fangdd Network Group Ltd. - Class A Ordinary Shares

Fangdd Network Group Ltd

Duolingo Inc

Duos Technologies Group, Inc. - Common Stock

Duos Technologies Group Inc

Duo World Inc

DUOPHARMA BIOTECH BHD ORD by Duopharma Biotech Berhad

Duopharma Biotech Bhd

DA Davidson analyst Gil Luria maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Neutral and raises the price target from $11 to $14.

News

Price Target

Analyst Ratings

PATH

DA Davidson Maintains Neutral on UiPath, Raises Price Target to $14

Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) has outperformed the market over the past 20 years by 4.14% on an annualized basis producing an average annual return of 12.41%. Currently, Extra Space Storage has a market capitalization of $32.01 billion. 
Buying $100 In EXR: If an investor had bought $100 of EXR stock 20 years ago, it would be worth $1,044.17 today based on a price of $150.81 for EXR at the time of writing.
<h3>Extra Space Storage's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748619918_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$100 Invested In Extra Space Storage 20 Years Ago Would Be Worth This Much Today

<a href="https://www.reuters.com/legal/government/astrazeneca-agrees-51-million-settlement-seroquel-antitrust-class-action-2025-05-30/#:~:text=May%2030%20(Reuters)%20%2D%20Drugmaker,to%20pay%20artificially%20higher%20prices.">https://www.reuters.com/legal/government/astrazeneca-agrees-51-million-settlement-seroquel-antitrust-class-action-2025-05-30/#:~:text=May%2030%20(Reuters)%20%2D%20Drugmaker,to%20pay%20artificially%20higher%20prices.</a>
May 30 (Reuters) - Drugmaker AstraZeneca has agreed to pay $50.9 million to settle a class action lawsuit in U.S. court accusing the company of scheming to delay a generic version of its schizophrenia drug Seroquel, causing companies to pay artificially higher prices.
The plaintiffs, a group of drug purchasers including Smith Drug Co and KPH Healthcare Services, filed the <a href="https://fingfx.thomsonreuters.com/gfx/legaldocs/jnpwlnonxvw/Seroquel%20XR%20(Extended%20Release%20Quetiapine%20Fumarate)%20Antitrust%20Litig..pdf">preliminary settlement, opens new tab</a> on Thursday in the U.S. District Court for the District of Delaware. The deal requires approval from U.S. District Judge Colm Connolly.
 The 2019 lawsuit alleged AstraZeneca schemed with Handa Pharmaceuticals to delay the marketing of a generic version of Seroquel XR, which is used to treat schizophrenia and bipolar disorder. Handa said it will pay $494,000 to settle the buyers' claims.
A trial had been scheduled for May 5.
AstraZeneca declined to comment. Handa and a lead attorney for the plaintiffs did not immediately respond to requests for comment.
AstraZeneca and Handa denied any wrongdoing in agreeing to settle. They said the resolution avoids the expense and distraction of any further litigation.
Worldwide annual sales of Seroquel once topped $5.3 billion. The class period covers business purchases from 2015 to 2017.
In their settlement filing, the plaintiffs' attorneys called the amount an "outstanding" result for the class of drug buyers.
The plaintiffs' lawyers said they would seek up to 36% of the settlement fund for legal fees, or about $18.5 million.
AstraZeneca in 2010 <a href="https://www.reuters.com/article/business/healthcare-pharmaceuticals/astrazeneca-us-settle-anti-psychotic-drug-case-idUSTRE63Q49J/">agreed to pay</a> $520 million to the U.S. government to settle claims that the company illegally marketed and promoted Seroquel for unapproved uses.
The company in 2011 <a href="https://www.reuters.com/article/legal/government/astrazeneca-in-685-mln-settlement-over-seroquel-idUSN10179553/">paid $68.5 million</a> to resolve U.S. states' claims over the alleged deceptive marketing of the drug.
The case is In re: Seroquel XR (Extended Release Quetiapine Fumarate) Antitrust Litigation, U.S. District Court for the District of Delaware, No. 1:20-cv-01076-CFC.

Legal

'AstraZeneca Agrees To $51 Million Settlement In Seroquel Antitrust Class Action' - Reuters News

Canaccord Genuity analyst Susan Anderson maintains Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) with a Buy and raises the price target from $510 to $542.

ULTA

Canaccord Genuity Maintains Buy on Ulta Beauty, Raises Price Target to $542

Goldman Sachs analyst Kate McShane maintains Bath &amp; Body Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) with a Buy and lowers the price target from $44 to $43.

BBWI

Goldman Sachs Maintains Buy on Bath & Body Works, Lowers Price Target to $43

Chardan Capital analyst Daniil Gataulin maintains uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) with a Buy and maintains $38 price target.

QURE

Chardan Capital Maintains Buy on uniQure, Maintains $38 Price Target

D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>) with a Buy and maintains $12 price target.

CLGN

D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target

Wolfe Research analyst Mike Polark initiates coverage on Beta Bionics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBNX#NASDAQ">BBNX</a>) with a Outperform rating and announces Price Target of $20.

Initiation

BBNX

Wolfe Research Initiates Coverage On Beta Bionics with Outperform Rating, Announces Price Target of $20

HP Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) shares have fallen 10% this week to $24.56, including a 0.14% drop on Friday. On Wednesday, the company reported mixed second-quarter earnings and cut its outlook.
What To Know: While HP&#8217;s <a href="https://www.benzinga.com/news/earnings/25/05/45659418/hp-stock-tumbles-as-q2-earnings-fall-short-of-estimates-guidance-comes-in-soft-due-to-higher-costs-related-to-tariffs">revenue</a> for the quarter came in at $13.22 billion, slightly ahead of analyst estimates of $13.15 billion, the company missed on earnings, posting adjusted EPS of 71 cents versus the expected 80 cents. 
CEO Enrique Lores highlighted strong commercial performance in the Personal Systems division but noted challenges from a "dynamic regulatory environment," including increased costs due to U.S. tariffs.
Looking ahead, HP guided for third-quarter earnings of 68 cents to 80 cents per share, well below analysts' 90 cent forecast. It also slashed its full-year earnings outlook from a range of $3.45–$3.75 to $3.00–$3.30 per share.
Analyst sentiment turned <a href="https://www.benzinga.com/25/05/45674650/these-analysts-slash-their-forecasts-on-hp-following-downbeat-earnings">more cautious</a> following the results. JPMorgan cut its price target from $30 to $27 while maintaining an Overweight rating. Barclays lowered its target from $36 to $28 and reiterated an Equal-Weight rating.
The disappointing earnings and guidance have weighed heavily on HP shares, which now trade near their lowest levels since early 2023.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">Fed&#8217;s Favorite Inflation Gauge Slows, But Trump&#8217;s China Accusation Flips Market Mood</a>
<h2 class="wp-block-heading">How To Buy HPQ Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in HP&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, HPQ has a 52-week high of $39.80 and a 52-week low of $21.21.

HP Stock Drops 10% Post-Earnings Miss, Outlook Disappoints

AZZ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZZ#NYSE">AZZ</a>) has outperformed the market over the past 5 years by 8.85% on an annualized basis producing an average annual return of 22.68%. Currently, AZZ has a market capitalization of $2.71 billion. 
Buying $1000 In AZZ: If an investor had bought $1000 of AZZ stock 5 years ago, it would be worth $2,855.84 today based on a price of $90.57 for AZZ at the time of writing.
<h3>AZZ's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748619044_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In AZZ 5 Years Ago Would Be Worth This Much Today

PTNM

Pitanium Shares Halted On Circuit Breaker To The Upside At $4.78/Share

Company Launches Far-Reaching Bitcoin Treasury Strategy
SARASOTA, Fla., May 30, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: <a href="https://www.benzinga.com/stock/djt#Nasdaq,%20NYSE%20Texas">DJT</a>) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has closed its previously announced private placement offering ("the Offering") with approximately 50 institutional investors.
The Offering consisted of the sale of (i) 55,857,181 shares of the Company's common stock, at a price of $25.72 per share, for gross proceeds of approximately $1.44 billion and (ii) 0.00% convertible senior secured notes due 2028 in the principal amount of $1.00 billion, at the conversion price of $34.72 per share, for an aggregate purchase price of approximately $2.44 billion. Trump Media will use the approximately $2.32 billion in net proceeds from the Offering to create a Bitcoin treasury and for other general corporate purposes and working capital.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

Trump Media Launches Bitcoin Treasury Strategy, After Closing $2.44B Private Placement With Institutional Investors

Despite years of positioning as "digital gold," Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) swift drop below $105,000 reveals a sobering truth: the asset still trades like high-beta tech, not a geopolitical hedge, though experts believe <a href="https://www.benzinga.com/markets/25/05/45602696/more-americans-now-hold-bitcoin-than-gold-report-says">a shift may be underway.</a>
What Happened: After President Donald Trump on Friday <a href="https://truthsocial.com/@realDonaldTrump/posts/114596705340367716">declared</a> on Truth Social that China had "totally violated" its trade agreement and warned that the U.S. is "no longer Mr. Nice Guy," markets responded swiftly.
Equities sold off, and Bitcoin, which had traded above $109,000 on Tuesday, retreated below $105,000 on early Friday.
That reaction prompted analysts and industry leaders to weigh in on what the move says about crypto's current and future position in institutional portfolios.
"Bitcoin's sharp drop underscores its sensitivity to macro shocks, challenging its narrative as a reliable hedge," Andy Lian, intergovernmental blockchain advisor and author, told Benzinga.
Lian acknowledged Bitcoin's growing appeal as a hedge against currency debasement and geopolitical instability but emphasized its continued volatility. 
Also Read: <a href="https://www.benzinga.com/cannabis/25/05/45692508/trump-administration-eyes-strategic-bitcoin-reserve-as-part-of-us-market-infrastructure-overhaul">Trump Administration Eyes Strategic Bitcoin Reserve As Part Of US Market Infrastructure Overhaul</a>
"It still dances to the tune of broader risk sentiment, correlating with equities during stress events," he noted, adding that institutional adoption remains hesitant due to these large price swings.
Speaking with Benzinga, Lingling Jiang, partner at DWF Labs, echoed the sentiment. "Bitcoin dropped to three-week lows after Trump's tariffs on China and others. That tells us crypto is still very much trading as a risk-on asset," she said. 
While Bitcoin is frequently touted as a hedge against inflation or global instability, Jiang said the data points in another direction: "Institutional flows still treat it like a high-beta tech play."
Why It Matters: Both experts believe the current volatility may actually signal a turning point, not a failure.
"Markets are trying to figure out what Bitcoin's role should be in a world where trade wars are becoming the norm," said Jiang. 
She believes this period of uncertainty could ultimately solidify Bitcoin's position as a strategic hedge, particularly if repeated geopolitical shocks normalize its use as a store of value.
Lian also pointed to a growing sentiment shift abroad. 
He cited a recent Chinese academic article, republished by the International Monetary Institution, which frames Bitcoin as a potential "strategic reserve asset." 
While not official policy, it suggests a possible rethinking of crypto's role even in traditionally skeptical jurisdictions.
Still, volatility remains the biggest hurdle. 
"Retail investors may accept the risk, but institutions—pensions, endowments—crave predictability," Lian said, noting that some may prefer gold or stablecoins until Bitcoin's swings stabilize.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/05/45691518/110m-wiped-out-bitcoin-whale-trader-gets-burned-as-btc-tags-104150">$110M Wiped Out: Bitcoin Whale Trader Gets Burned As BTC Tags $104,150</a></li>
</ul>
Image: Shutterstock

Bitcoin Drops To $105,000 After Trump Warns He's 'No Longer Mr. Nice Guy'

Scotiabank analyst Patrick Colville maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Sector Outperform and raises the price target from $242 to $310.

Scotiabank Maintains Sector Outperform on Zscaler, Raises Price Target to $310

Shares of Galaxy Digital Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLXY#NASDAQ">GLXY</a>) fell 5.65% to $18.49 during Friday trading after the company announced an increase in the size of its underwritten public offering.
What To Know: The digital asset and infrastructure firm <a href="https://www.benzinga.com/pressreleases/25/05/n45685251/galaxy-digital-inc-announces-pricing-of-its-upsized-public-offering-of-common-stock">priced</a> 31.6 million Class A common shares at $19.00 each, up from a previously announced 29 million shares. The offering includes 26.4 million shares from Galaxy and 5.2 million from existing shareholders.
Underwriters have a 30-day option to purchase up to 4.74 million additional secondary shares. The offering is expected to close on June 3, pending customary conditions.
Proceeds from Galaxy's <a href="https://www.benzinga.com/pressreleases/25/05/n45685251/galaxy-digital-inc-announces-pricing-of-its-upsized-public-offering-of-common-stock">portion of the sale</a> will be used to acquire newly issued units from its operating subsidiary, Galaxy Digital Holdings LP, which will allocate the funds toward expanding its AI and high-performance computing infrastructure at the Helios data center in West Texas, along with general corporate purposes. Galaxy will not receive proceeds from shares sold by existing shareholders.
Goldman Sachs, Jefferies and Morgan Stanley lead the joint book-running efforts for the offering, with multiple additional financial firms acting as co-managers.
Read Also: <a href="https://www.benzinga.com/cannabis/25/05/45693219/feds-favorite-inflation-gauge-slows-but-trumps-china-accusation-flips-market-mood">Fed&#8217;s Favorite Inflation Gauge Slows, But Trump&#8217;s China Accusation Flips Market Mood</a>
<h2 class="wp-block-heading">How To Buy GLXY Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Galaxy Digital&#8217;s case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GLXY has a 52-week high of $35.30 and a 52-week low of $11.27.
Image: Shutterstock

GLXY

Galaxy Digital (GLXY) Shares Slide 5% Following Upsized Public Offering Announcement

Scotiabank analyst Ben Isaacson maintains Sociedad Quimica Y Minera (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQM#NYSE">SQM</a>) with a Sector Outperform and lowers the price target from $50 to $45.

Scotiabank Maintains Sector Outperform on Sociedad Quimica Y Minera, Lowers Price Target to $45

Scotiabank analyst Mike Rizvanovic maintains Royal Bank of Canada (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RY#TSX">RY</a>) with a Sector Outperform and lowers the price target from C$188 to C$186.

TSX:RY

Scotiabank Maintains Sector Outperform on Royal Bank of Canada, Lowers Price Target to C$186

<a href="https://www.cnet.com/tech/services-and-software/victorias-secret-takes-down-us-website-after-security-incident/" title="https://www.cnet.com/tech/services-and-software/victorias-secret-takes-down-us-website-after-security-incident/">https://www.cnet.com/tech/services-and-software/victorias-secret-takes-down-us-website-after-security-incident/</a>

VSCO

'Victoria's Secret U.S. Website Back Up After Security Incident; The Lingerie Retailer Briefly Took Down Its Site Earlier This Week As A Security Precaution' - CNET

<a href="https://www.bloomberg.com/news/articles/2025-05-30/microsoft-s-zenimax-reaches-contract-deal-union-says?srnd=homepage-americas&amp;embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-05-30/microsoft-s-zenimax-reaches-contract-deal-union-says?srnd=homepage-americas&amp;embedded-checkout=true</a>

General

MSFT

'Microsoft's ZeniMax Reaches Contract Deal, Union Says'- Bloomberg

IPOs

Pitanium IPO Shares Open For Trade At $4.51/Share; IPO Priced At $4/Share On 1.75M Shares

Press Releases

Leading the Charge: PRSO, DUO, INDO, RIG, MTC – Energy and Technology Stocks Poised for Continued Gains

Financing

FangDD Announces Pricing of US$5.0 Million Registered Direct Offering

FangDD Announces Pricing of US$4.5 Million Registered Direct Offering

FangDD Regains Compliance with Nasdaq Minimum Bid Price Requirement

Fangdd Announces Pricing of US$5 Million Registered Direct Offering

Fangdd Announces Pricing of US$7.0 Million Registered Direct Offering

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

FangDD Announces US$5,000,000 Senior Convertible Notes Offering

FangDD Files 2024 Annual Report on Form 20-F

INDO

PRSO

Antelope Enterprise Holdings Limited - Class A Ordinary Shares

Antelope Ent Hldgs

BuzzFeed

Cheer Holding, Inc. - Class A Ordinary Share

Cheer Holding

Phoenix New Media Limited American Depositary Shares, each representing 48 Class A ordinary shares.

Comments

Fangdd Network Group

Fangdd Network Group (DUO) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL